INTRODUCTION
Prion proteins are unique because they adopt at least two distinct conformational states, one of which, the prion form, can stimulate the nonprion conformation to convert into the prion form. The term "prion" first described the unusual proteinaceous infectious agent that causes devastating neurodegenerative diseases of mammals called transmissible spongiform encephalopathies (TSEs) (128) . TSEs include mad-cow disease of cattle, scrapie of sheep and goats, as well as CreutzfeldtJakob disease and Kuru of humans (129) . Most transmissible diseases are caused by nucleic acid-based agents; however, TSEs are probably caused by the aberrant folding of a cellular protein (PrP C ) into an infectious form (PrP Sc ) (129) . The function of PrP C is unknown. Although the protein-only nature of the infectious agent has not been unequivocally demonstrated, protein conformational change is closely linked to transmissibility.
The revolutionary prion concept has been extended to explain three unusual genetic elements of the yeast Saccharomyces cerevisiae and one of the filamentous fungus Podospora anserina (35, 147, 176) . The term prion is no longer confined to the infectious agent of TSEs, but applies to any protein that can switch to a self-sustaining conformation. The agents of the four fungal prions are four endogenous cellular proteins, which participate in diverse biological processes and are apparently nonhomologous to each other or to the mammalian prion protein.
The conformational switch to the prion state alters the protein's function and the cell's phenotype. The altered phenotypes are propagated from generation to generation as the protein in the prion state is transferred from mother to daughter cell, continuing the cycle of conformational conversion. Thus, yeast prions act as heritable protein-based genetic elements that cause biologically important phenotypic changes without any underlying nucleic acid change.
The yeast prion [PSI + ] is caused by a conformationally altered form of Sup35 (122, 123, 176) , one of two proteins that comprise the translational release factor (152) . Some mutant Sup35 proteins cause ribosomes to read through stop FUNGAL PRIONS 
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codons at an appreciable frequency (71, 72) . Such mutants suppress nonsensecodon mutations in other genes, hence their name. [PSI + ] strains also display a nonsense-suppression phenotype (38) because translational termination becomes impaired when Sup35 adopts the prion conformation (Figure 1 ; for nomenclature, see Figure 3 ). Unlike the recessive phenotype of sup35 mutations, [ ] cells, most Sup35 proteins adopt the prion conformation and self-assemble into an aggregated, possibly amyloid structure (depicted as large cylinder). This conformational change impairs Sup35's ability to participate in translational termination and consequently, stop codons are read through occasionally, producing proteins with a C-terminal extension. dominant, characterized by non-Mendelian inheritance, and efficiently transmitted from mother cell to daughter through the cytoplasm (38, 40). (The brackets in the name [PSI + ] denote the latter two characteristics, and the uppercase and italicized PSI denotes a dominant trait).
The prion [URE3] affects nitrogen catabolite repression. Normally, yeast growing on rich nitrogen sources such as ammonium repress production of proteins needed to metabolize poor nitrogen sources such as ureidosuccinate (158) . Recessive mutants termed ure were isolated that utilize poor nitrogen sources in the presence of good sources (95, 96) . The Ure2 protein regulates nitrogen catabolism by binding to and interfering with the transcriptional activator Gln3 (10) . One dominant variant, called [URE3], showed non-Mendelian inheritance and was cytoplasmically transferable (2, 96) . Conversion of Ure2 into its prion form renders Gln3 constitutively active, thereby eliminating nitrogen catabolite repression and enabling yeast to utilize ureidosuccinate in the presence of ammonium (176) (Figure 2 ).
Another yeast prion was identified by a directed computer search of yeast genome databases based upon its similarity to regions of Sup35 and Ure2. Rnq1, so named because its sequence is rich in asparagine (Asn, N) and glutamine (Gln, Q), is the protein determinant of the prion [ ] induction, providing the first evidence that one prion affects the appearance of another (45, 118) .
The [Het-s] prion of P. anserina mediates heterokaryon incompatibility. Because mycelia of this fungus can fuse, resulting in cytoplasmic mixing and occasional exchange of nuclei, this organism has a mechanism to prevent heterokaryon formation between incompatible strains (134) . Heteroallelism between any of as many as nine het loci triggers a lytic reaction that leads to cell death via an uncharacterized mechanism (134) . On solid media, accumulation of these dead cells leads to a distinct, easily visible abnormal contact line, termed a barrage. There are two alleles at the het-s locus called het-s and het-S. The het-s allele encodes a protein with two different conformations: HET-s behaves as a prion and HET-s * does not (35). The het-S allele encodes the HET-S protein that is incompatible with [Het-s] prion strains but is compatible with neutral [Het-s * ] strains (for nomenclature, see Figure 3 ).
Here, we review the literature on [PSI + ], [URE3], [RNQ + ], and [Het-s], focusing on their common characteristics, the mechanisms by which they are induced and propagated, their biological significance, and their possible roles in evolution. A comprehensive analysis of the many intricacies of these fascinating elements is beyond the scope of this review. Fortunately, many extensive reviews of individual prions are available (23, 129, 141, 143, 178 ) and we urge interested readers to consult them. Because many other unidentified prions probably exist (113, 143, 147) , we seek to aid the reader in ascertaining whether proteins with unusual conformational Figure 2 The effect of [URE3] on Ure2 and ureidosuccinate uptake. (A) In nonprion [ure-o] cells, uptake of poor nitrogen sources such as ureidosuccinate and allantoate is repressed in the presence of good nitrogen sources such as glutamine and ammonia. The availability of good nitrogen sources is relayed through Ure2 (see legend at bottom), which blocks the action of the transcription factor, Gln3. Without transcriptional activation, the allantoate transporter, Dal5, is not produced. (B) In [URE3] cells, conversion of Ure2 into its prion conformation interferes with its ability to repress Gln3. Thus, even in the presence of preferable nitrogen sources, Gln3 activates the transcription of DAL5. Ureidosuccinate is a structural mimic of allantoate and enters the yeast cell via Dal5.
708

UPTAIN LINDQUIST
Figure 3
Summary of fungal prion nomenclature. This is a brief guide to the nomenclature and terminology of fungal prions and their associated alleles and phenotypes. The yeast prion nomenclature is in accordance with the accepted rules for yeast nomenclature (142) .
properties or genetic traits with unusual epigenetic properties are prion-like. We hope that highlighting the distinctiveness and variety of prion behavior will fuel discovery of novel prions.
CHARACTERISTICS OF FUNGAL PRIONS
The four fungal prions, particularly [PSI + ] and [URE3], share many characteristics ( Figure 4 ) that are widely cited as criteria to identify novel prions. Indeed, these criteria led to the identification of other prion elements (133, 147) and undoubtedly will lead to the discovery of more. There are some notable differences
, and [Het-s], however, making it likely that prions differing in key aspects will be found. Ultimately, to be a prion we suggest that a protein must fulfill only one requirement: It must adopt at least two stable states, one of which is self-sustaining.
Fungal Prions are Metastable
Prions occur spontaneously in laboratory fungal strains at a low frequency. [ (23, 26, 47) . Overexpressing the gene encoding a prion increases the induction rate several orders of magnitude (22, 24, 35, 50, 110, 147, 176) , presumably because this increases the chance that some proteins will spontaneously adopt the prion conformation. Importantly, [ Once established, most prions propagate faithfully through mitosis and meiosis and are rarely spontaneously lost, although there are some exceptions (9, 35, 40, 176) . Stability differences can be attributed to genetic background (96, 108) Altering the expression of cellular proteins that affect protein folding can also cure prions. All three yeast prions require Hsp104, a molecular chaperone that resolves misfolded protein aggregates (70, 121) , and are irreversibly cured when HSP104 is deleted (26, 114, 147 ] lysates are fractionated using size-exclusion chromatography, the prion form of Sup35 is associated with high-molecular-weight fractions (123) . The Sup35 prion conformation is somewhat more resistant to proteinase K digestion than the nonprion form (122, 123) . Together, these studies indicate that Sup35 and Rnq1 are aggregated in the prion state but not in the nonprion state, which provides a satisfying explanation for the translational termination defect of [PSI + ] strains.
To visualize the prion conformation converting newly made protein to the prion state in living cells, Rnq1 or certain prion-determining fragments of Sup35 were fused to green fluorescent protein (GFP) and expressed in yeast. In cells without either prion, these GFP fusion proteins distribute evenly throughout the cytoplasm (122, 147 (104) .
Similar approaches indicated that the prion forms of Ure2 and HET-s are aggregated in prion-containing cells; however, the nature of this conformational difference is not as well understood as with Sup35 and Rnq1. In some genetic backgrounds, the prion form of Ure2 is more resistant to proteolysis than the nonprion form (111, 137, 162 (17) . The fiber's width varies depending on the prion and solution conditions (range: 4-22 nm) but is proportional to the molecular weight of the monomer (5, 53, 69, 81, 138, 156, 162) . Fibers can be short or tens of microns long (53, 69, 162) . Like other amyloids, prion fibers are rich in β-sheet structure (53, 69, 156) and exhibit a cross-β-pleated-sheet pattern by X-ray diffraction (5, 140) .
Biochemical characterization of prion amyloid formation provided remarkable insight into the probable molecular mechanism by which prions arise and propagate in vivo. Just as prions arise spontaneously, but infrequently, in cells (2, 8, 38, 105, 108, 176) , each prion protein forms fibers spontaneously, but slowly, in vitro (53, 69, 146, 156) . Mutations that increase or decrease the rate of prion induction in vivo correspondingly affect fiber formation in vitro (44, 69, 105) . Because most fungal prions are mitotically stable, some process must facilitate efficient conversion of nascent prion proteins into the prion conformation. Remarkably, small amounts of pre-existing amyloid can promote rapid conversion of unpolymerized prion proteins into fibers in vitro (53, 69, 81, 146, 156 (69, 124, 168) . Thus, amyloid formation in vitro serves as a model for how prions act as heritable elements in vivo.
Prions Require Sustained Expression of Their Determinant Genes, Yet Their Phenotypes Often Mimic Loss-of-Function Mutations
Although the fungal prions act as genetic elements, their maintenance depends upon continual expression of the genes encoding them (176) . Poor or interrupted expression leads to the eventual loss of the prion (99, 147, 176) . It is not surprising, therefore, that SUP35, URE2, and RNQ1 are all expressed at nearly constant levels throughout the cell cycle (43, 150).
The conformational change to the prion state often decreases the protein's activity. Aggregation may sequester a prion from its substrate or impede its proper localization within the cell. Thus, the phenotypes of prions mimic loss-of-function mutations in their prion determinants (176 ] by using strains that have a nuclear mutation that allows the cytoplasm of the two cells to mix upon mating but prohibits fusion of their nuclei (cytoduction) (2, 31, 40, 147) . Subsequent experiments demonstrated that [PSI + ] and [URE3] were not caused by other cytoplasmically transferred genetic determinants, such as mitochondrial DNA, viruses, or plasmids (68, 96, 97, 164, 185) .
The dominant, non-Mendelian, and cytoplasmic character of these unusual genetic elements is consistent with a self-perpetuating protein-based mechanism of inheritance. The prion conformation is self-propagating, unlike most protein aggregates. During mating, haploid yeast fuse, mixing cytoplasmic contents and allowing the prion conformation to convert proteins from the [prion − ] cytoplasm into the prion conformation. Upon cell division, the prion conformation is passed from the mother cell to the daughter cell through the cytoplasm.
The [Het-s] prion of P. anserina can also be transferred cytoplasmically (8, 35 
Prion-Determining Region (PrD)
Sup35 contains three regions that are distinguished by their function and amino acid composition (78, 93, 94, 157, 180) . The amino-terminal region, termed Sup35N (amino acids 1 to 123), is unusually rich in Gln (28%) and Asn (16%) residues, but has few aliphatic amino acids (e.g., alanine and valine, 6%) ( Figure 5 ). By comparison, the average protein has just 9% Gln and Asn (133) and 29% aliphatic residues (112) . Sup35N also contains several imperfect oligopeptide PQGGYQQ YN repeats that are similar in character to PHGGGWGQ repeats present in the mammalian prion protein, PrP (85, 105, 120) . These repeats are the only immediately obvious similarity between Sup35 and PrP protein sequences. The middle region, Sup35M (amino acids 124 to 253), is highly charged, unlike the rest of the protein.
Forty-one percent of the residues in this region are lysine, glutamic acid, or aspartic acid. Sup35NM is not required for viability (160) ; however, Sup35C (amino acids 254 to 685) is essential (91, 160) . Sup35C is homologous to the translation elongation factor EF-1α, contains four putative GTP-binding sites, and is sufficient for translational termination (78, 94, 152, 180) . Ure2 and Rnq1 are also Gln-and Asn-rich proteins. Each can be subdivided into two functionally distinct regions. Ure2N [amino acids 1 to 93 (126, 162) ] contains more Asn (36%) than Gln residues (11%) ( Figure 5 ), and only 13% of its residues are aliphatic. The remainder of the protein, Ure2C (amino acids 94 to 354), encodes the nitrogen regulatory activity of Ure2 (33) and is homologous to bacterial glutathione S-transferases (GST), although it lacks GST enzymatic activity (13, 29, 33, 167) . The Rnq1C (amino acids 153 to 405) has many Asn (16%) and Gln (27%) residues and contains few aliphatic residues (8%) (147) . Rnq1N (amino acids 1 to 152) is not similar to any other protein and its function is unknown (147) . Neither Ure2 nor Rnq1 are essential for viability (33, 147) and neither contains oligopeptide repeats similar to those of Sup35 or PrP.
Remarkably, distinct regions of Sup35, Ure2, and Rnq1, which are similar in character but not identical in sequence, enable these protein to act as prions and are called prion-determining regions (PrDs (69, 104, 160) . That Ure2C is dispensable for prion propagation was demonstrated by passaging the prion through strains lacking this region (110) .
sup35 and ure2 mutants that affect prion induction and propagation cluster to their N-terminal regions (44, 50, 52, 62, 105, 109, 111, 120) . Most reduce the Asn and Gln content of these proteins or the number of oligopeptide repeats in Sup35, indicating that these two characteristics are important for these regions to function as PrDs. The absolute ratio of Asn to Gln is not crucial because [PSI + ] can be induced by overproducing a fusion of a mutant Sup35N region to GFP, in which a polyGln stretch replaced an Asn-and Gln-rich stretch (44).
Because prions are induced more frequently when their determinants are overexpressed, several groups measured the efficiency with which [PSI + ] and [URE3] arose when various prion protein subfragments were overproduced. Elevated expression of any fragment containing Sup35N or Ure2N increases the rate of prion induction (24, 50, 83, (109) (110) (111) 176) . These fragments induce prion formation much more efficiently than full-length versions expressed at similar levels (50, 83, 109, 111 ], and [ure-o] cells, the fluorescence is evenly distributed throughout the cytoplasm. In another case, the PrD of Sup35 was fused to a completely unrelated protein to create a novel chimeric prion. The mammalian glucocorticoid receptor (GR), a hormone-regulated transcriptional activator, was fused to the PrD of Sup35 and expressed in a strain bearing a GR-regulated lacZ reporter. This fusion protein can exist in two stable but interchangeable functional states, only one of which activated transcription of the reporter (99) . Importantly, the fusion protein exhibited many of the unusual genetic characteristics of known yeast prions, and it converted to the nonfunctional state on its own in a mutant [psi − ] strain in which the endogenous Sup35 PrD was deleted.
The 289-amino-acid HET-s protein is the only identified fungal prion not Asn or Gln rich (166) and without a well-defined PrD. To identify regions important for conversion to the [Het-s] prion state and for heterokaryon incompatibility, a series of het-s deletion mutants were ectopically expressed in a het-s 0 strain (36). An N-terminal fragment (amino acids 1 to 112) is sufficient for incompatibility and for conversion to [Het-s], suggesting that it contains the PrD. Consistent with this interpretation, point mutations in this region affect prion propagation (36). Further analysis revealed that a C-terminal fragment (amino acids 86 to 289) also mediates incompatibility and conversion. Although this suggests that the 27-amino-acid region common to both fragments is the minimal PrD, a fragment lacking only that region also supports incompatibility and conversion. Thus, no specific PrD was identified. Interestingly, an even shorter N-terminal fragment (amino acids 1 to 25) propagates the [Het-s] phenotype (36) but cannot mediate heterokaryon incompatibility.
PRION CANDIDATES
Yeast and filamentous fungi have other traits with unusual genetic properties that resemble those of prions (Figure 4 ). Although they are not yet characterized enough to judge whether they are caused by prions, all can be transmitted cytoplasmically. Most display non-Mendelian inheritance and are metastable and curable. However, some of their characteristics, such as not being cured by GuHCl treatment, are unlike those of known prions. If any are prions, those unique characteristics will broaden the criteria for identifying prions and aid the search for novel prions.
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[C + ]
Crippled growth, [C + ], is a cytoplasmically transferable trait of P. anserina that impairs mycelial growth, hence its name (144) . It also causes abnormal hyphal morphology, pigment accumulation, shortened longevity, and reduced female fertility (144 [GR]
[GR] is a cytoplasmically transferable trait of S. cerevisiae that provides resistance to glucosamine, a glucose analog that inhibits growth on nonfermentable carbon sources (6, 60 GRR1 is a plausible candidate for the determinant of [GR] (146) . Grr1 is a component of the ubiquitin proteolysis machinery and appears to regulate the glucose signaling pathway and cell cycle progression (98) . Grr1 contains several runs of polyAsn residues at its N and C termini. grr1 deletion strains exhibit pleiotropic phenotypes related to loss of degradation of key regulatory proteins, some of which, including glucosamine resistance, are also exhibited by [GR] strains (65, 146, 183 
PRION STRAINS
One of the most controversial aspects of mammalian prions is the existence of distinct TSE strains, which differ in their disease latency periods, brain pathologies, neuropathological manifestations, and distribution of PrP Sc in brain tissues (14, 16) . Some clinically distinct human prion diseases are caused by mutations in the prion protein gene, Prnp (129) . However, prion strains cannot be due to any mutations in Prnp or elsewhere in the mouse genome because they are passaged in the same inbred mice background. Opponents of the protein-only hypothesis argue that a viral TSE agent best explains prion strains (15, 51, 139) ; proponents posit that PrP Sc conformational differences cause strains (20, 129, 139) . Such conformational variation is present because different positions of cleavage occur upon protease treatment of infectious material from different strains [reviewed in (20, 30) ]. Whether this is the underlying basis of mammalian prion strains remains unclear.
[ (137) . A novel reporter system involving the adenine biosynthesis pathway was developed to detect them (137) . On rich media, Ade2-deficient cells are red because they accumulate a red metabolic intermediate, whereas wild-type cells are white. When ADE2 expression is controlled by the DAL5 promoter, [ure-o] colonies are red because Ure2 keeps Gln3 in the cytoplasm, the DAL5 promoter is not activated, and ADE2 is not expressed. Most [URE3] strains are pink or white. Type A [URE3] variants are pink and more difficult to cure than type B variants, which are redder. Type C variants are red and unlike the other two types of variants, they have soluble Ure2 and cannot be cured by GuHCl treatment or transferred by cytoduction (137) . Although the molecular basis of these variants is unknown, no differences in the prion conformation of Ure2 were detected by proteinase K digestion (137) . One attractive possibility is that differences in prion conversion efficiency similar to that of Sup35 may underlie them (137, 168) .
What might lead to the differences in conversion efficiencies in yeast prion variants? Prion proteins may adopt conformations with intrinsically different abilities to convert the nonprion form into the prion form. Indeed, purified Sup35NM can form amyloid fibers with different structural states in vitro (69 ] variants, they are not retained in the cell-free system. Perhaps interactions between the prions and other cellular factors, which might be stochastic in origin but self-perpetuating in nature, maintain variants in vivo. Alternatively, if prion aggregates of stronger variants were smaller and more numerous than those of weaker variants, they might convert soluble Sup35 more effectively and be propagated more faithfully in vivo, but not be sustainable in vitro.
YEAST PRIONS AS PROTEIN-BASED HERITABLE ELEMENTS
The ability of fungal prions to act as protein-based elements of inheritance depends upon two key processes: induction, whereby a protein spontaneously converts to the prion state, and propagation, which depends upon efficient, continual conversion of newly synthesized prion protein and partitioning of the prion conformation to daughter cells before cytokinesis. Since Wickner's (176) remarkable proposal that [URE3] and [PSI + ] are prions, an explosion of studies have provided notable insight into the mechanism of induction and propagation. Indeed, today much more is known about induction and propagation of yeast prions than mammalian prions (19) .
Induction, Propagation, and Curing
Any model for prion induction must account for several general observations. (45, 47) . Stabilizing the prion state may be more difficult for some prion-like proteins than others, and some may never complete this maturation period (45, 118) . Perhaps a certain number of conversion events must occur to cross a threshold of stabilization. Alternatively, some proteins may adopt the prion conformation more readily than others.
Tremendous insight into how prions are induced and propagated came from studying the self-perpetuating conversion of prions in vitro. Conformational conversion of prion proteins into amyloid fibers proceeds by a cooperative process, which can be subdivided into a lag phase, during which nuclei form, and a templated assembly phase, which is characterized by rapid conversion of soluble proteins as it interacts with nuclei (53, 69, 81, 138, 140, 147, 162) . The lag phase can be quite long and is reminiscent of the slow rate of spontaneous prion induction in vivo. It can be shortened, or even eliminated, by adding small amounts of preformed converted protein at the onset, mimicking how pre-existing prions convert newly synthesized protein in vivo.
The (69, 124, 168) . Mutations that increase or decrease the rate of prion induction correspondingly alter the rate of amyloid formation in vitro (44, 105). The structural characteristics of Sup35 appear to be optimized to allow conversion (135) . The optimal temperature for Sup35NM assembly into amyloid is [25] [26] [27] [28] [29] [30] • C, coinciding with the optimal growth temperature of yeast (135) . Finally, [PSI + ] can be induced, albeit inefficiently, by introducing purified, recombinant Sup35NM into the yeast cytoplasm using a liposome transformation method (149) . Although the conformational state of the Sup35NM used in the protein transformation experiments could not be determined, it also accelerated Sup35NM conversion in vitro.
Although prion proteins form amyloid fibers in vitro, it is not clear if the mature prion conformation in vivo is amyloid fibers. Amyloid-like filaments were detected by thin-section electron microscopy and immunogold-labeling (137) when prion-GFP fusions are overproduced. Thus, the prions can promote the formation of amyloid-like filaments in yeast when highly overproduced, but perhaps not under wild-type conditions. Perhaps, one or more of the structural intermediates identified during formation of prion amyloids in vitro might constitute the prion state in vivo (67, 140, 161 (57) . This is a particularly perplexing phenomenon because overexpressing fulllength URE2 efficiently induces [URE3] (176) . Adding to the complexity, those same fragments or GFP fusions do not cure when overexpressed at low levels (57) . Possibly, the overproduced proteins interfere with [URE3] propagation by interacting with wild-type Ure2 prion aggregates. Alternatively, a factor that cures the prion, such as a molecular chaperone, may be induced, or a limiting factor necessary for [URE3] propagation may be consumed.
One mystery is how prions are partitioned from one cell to another. Clearly, this process is efficient. Most yeast prions are mitotically stable and [prion − ] cells rarely appear spontaneously (38, 96) . It is widely assumed that the partitioning of prion particles occurs stochastically as a portion of the yeast cytoplasm containing many prion particles is passed from mother cell to daughter. However, prion aggregates might segregate by an active mechanism, perhaps analogous to organelle partitioning (18, 170 (12, 25, 88, 104) . Usually, prions are equally stable during meiosis and mitosis, although in rare instances these can be uncoupled (74) .
FACTORS THAT MODULATE PRION INDUCTION FREQUENCY
Certain mutations in prion determinants or in other genes increase the rate of spontaneous prion induction. The most effective sup35 mutant tested contains two additional oligopeptide repeats. [PSI + ] arises 5000-fold more frequently in this mutant background (105) . Compared to wild-type Sup35, this mutant protein is less structured and forms amyloid fibers more readily in vitro (105, 135) . A Sup35 mutant lacking some of the repeats was more structured than wild-type and underwent conversion much less efficiently (105, 135) . This and other work suggest that conformational flexibility increases prion induction frequency. Several ure2 mutants increase the rate of [URE3] induction, one (h2) as much as 1000-fold over the wild type (62) . Unexpectedly, most of the 10 amino acid substitutions in h2 that affect induction map outside the PrD. Perhaps these mutations destabilize normal Ure2 interactions with itself or with other proteins, allowing the PrD to exert a stronger influence on conversion.
[ is not caused by just one prion protein; rather, it is a susceptibility state in which the presence of any one of several different prions makes it more likely that a second prion will form (45, 118). One hypothesis is that one protein in the prion state can, with low efficiency, nucleate conversion of another to the prion state through a direct interaction (45, 118). Preliminary work with New1 and Sup35 failed to detect heterotypic interactions or cross-nucleation (118 ]-mediated translational read through, and the amount of soluble Sup35 are unaffected in sla1 deletion strains (3). Sla1 may play some role in translation because sla1 deletion strains are sensitive to translational inhibitors (3) . If Sla1 interacts with some aspect or component of translation that also interacts with Sup35, SLA1 overexpression may titrate factors that normally limit Sup35 conversion. Alternatively, Sla1 may promote prion induction by interacting with Sup35.
As noted earlier, Hsp104 expression is required for all well-characterized yeast prions. Other chaperones can affect induction of [PSI + ], and perhaps induction of other prions. Two Hsp70 members, SSB1 and SSB2, associate with the ribosome and nascent polypeptide chains and may function in cotranslational protein folding (11, 116, 127) . Intriguingly, [PSI + ] spontaneously arises 10 times more often in ssb1, ssb2 deletion strains than in wild-type strains (27). Perhaps conformational conversion to the prion state occurs cotranslationally, and SSB1 and SSB2 chaperone Sup35 folding into the translationally active nonprion form.
At least one signal transduction pathway can modulate [URE3] induction. Mks1 negatively regulates URE2 in the nitrogen catabolite repression cascade (58) . In response to environmental cues, Mks1 acts indirectly to positively regulate DAL5, the permease that imports ureidosuccinate (58) . Mks1 is unnecessary for [URE3] propagation because the prion can be transferred to a [ure-o] mks1 deletion strain by cytoduction (59) . However, the efficiency of [URE3] induction is higher in strains overexpressing MKS1 and is several orders of magnitude lower in mks1 deletion strains. Mks1 does not alter the steady-state levels of Ure2 (58), and the mechanism by which it modulates [URE3] induction is yet to be discovered.
AGENTS THAT CAN CURE FUNGAL PRIONS
A great variety of chemical, environmental, and protein-based agents cure yeast prions. These agents differ in curing efficiency, action, and specificity. In principle, curing agents may impair conformational conversion, inhibit partitioning to the daughter cell, or both. [PSI + ] and [Het-s] strains are readily cured if grown on media containing various solutes at high osmotic strength (9, 35, 145, 165) . In contrast, [URE3] is selectively cured by switching from minimal media with ureidosuccinate to rich media with other nitrogen sources (137) There is a lag phase of several generations before cells are cured, possibly because the numerous pre-existing prion particles are diluted with each cell division (56). It is unclear whether GuHCl cures by inactivating Hsp104 or by some other mechanism. Certainly, at low concentrations, GuHCl lowers the ATPase activity of Hsp104 in vitro (70) . GuHCl also inhibits cells from acquiring thermotolerance and from refolding thermally denatured luciferase, two processes that require active Hsp104 (64, 75 
The Role of Hsp104 in Prion Induction and Propagation
The molecular chaperone Hsp104 resolves thermally denatured proteins (70, 121 The other model posits Hsp104 simply disaggregates Sup35 prion aggregates, which creates many smaller aggregates that are more likely to be partitioned to the daughter cell (90, 123) . Without Hsp104, fewer and larger aggregates accumulate, reducing the probability that enough prion proteins will partition to the daughter. High Hsp104 levels cure [PSI + ] cells simply because all prion aggregates are resolved. Unlike the first model, Hsp104 is not needed to convert Sup35 to the prion state.
Both models predict that Hsp104 interacts with Sup35. Stable complexes of Hsp104 with Sup35, or any other yeast prion, have not been detected; but there is indirect evidence for a transient interaction (136) . Sup35 inhibits the ATPase activity of Hsp104 in vitro, and the circular dichroism spectrum of a mixture of Hsp104 and Sup35 differs from that predicted by adding these proteins' individual spectra (136) . Whether this interaction is necessary to convert Sup35 or to disrupt prion aggregates is less clear. Indeed, it may do either, depending on the presence of other chaperones. Consistent with the first model, Sup35 amyloid formation proceeds through an oligomeric state that forms without Hsp104 in vitro (69, 140) . When Sup35-GFP fusions are expressed at low levels in [psi − ] hsp104 deletion strains, no punctate fluorescent foci are visible. Expressing the fusion at higher levels overcomes the apparent requirement for Hsp104 (69) 
The Role of Other Molecular Chaperones in Prion Induction and Propagation
[PSI + ] is cured inefficiently or not at all by many conditions that dramatically raise the level of Hsp104, including heat shock, or sporulation (131, 132, 145, 165) . This was initially surprising because high HSP104 overexpression cures [PSI + ] efficiently (26) . Perhaps curing requires cellular division, which does not occur during heat shock, or other factors that are induced that counteract the effect of higher Hsp104 levels.
One such candidate is the heat-inducible molecular chaperone Hsp70. Yeast have four functionally redundant and nearly identical cytosolic Hsp70 proteins called Ssa1-4 (11, 41, 42) . Ssa1 is constitutively expressed, but its level increases two-to threefold after heat stress (173, 174) . Hsp104 overproduction cures [PSI + ] less effectively, and less Sup35 becomes soluble when Ssa1 is also overproduced (117) . In contrast, overproduction of Ssb1 or Ssb2, two Hsp70 relatives that are not heat inducible (106, 172) Because Hsp40s can specify the substrates of Hsp70-Hsp40 complexes (76), they may direct which prions and chaperones interact. Despite the importance of chaperones in prion propagation, only one stable interaction between chaperones and prions has been identified. The cytosolic Hsp40 Sis1 is essential for viability and required for translational initiation (107, 186) . The glycine-and phenylalanine-rich (G/F) region of Sis1 partly determines the chaperone's specificity (182) . Rnq1 only binds stably to Sis1 when it is in the prion state, and [RNQ + ] cannot be propagated in a sis1 mutant lacking the G/F region (148) . Figure 6 ).
EVOLUTIONARY AND BIOLOGICAL SIGNIFICANCE OF PRIONS
To determine if Sup35NM might be adaptive, the extent of nucleotide polymorphism within many laboratory, commercial, and clinical isolates of S. cerevisiae in Sup35 was compared to the extent of sequence divergence of a related species, S. paradoxus (73) . The amino acid sequences of Sup35N, M, and C are constrained to varying extents, presumably by purifying selection against mutations that change a coding sequence. Sup35C is under strong constraint, presumably because of its essential role in translational termination; Sup35NM also appears to be under selection, albeit more weakly.
What might be the function of the N-terminal PrD-like regions of Sup35 and Ure2 homologs? Certainly, the PrDs of S. cerevisiae are not essential for translational termination or for nitrogen catabolite repression (33, 160), although nitrogen regulation of Gln3 is somewhat diminished when the PrD of Ure2 is deleted (86 (163) . Sup35N may link translation to the cytoskeleton via its interaction with Sla1, or it may play a role in glucose metabolism by interacting with Reg1 and Eno2 (3). A more interesting possibility is that a putative PrD is conserved to produce a prion, and thereby epigenetically modify the function of the protein domain to which it is attached. Remarkably, all could induce and propagate a prion-like state if the corresponding heterologous SUP35 homolog was also expressed (25, 88, 115, 133) .
Strikingly, the amino acid sequences of homologus PrDs are divergent, precluding precise sequence alignment. Moreover, the ratio of Asn to Gln residues varies tremendously, even between homologous PrDs. [Compare the S. cerevisiae Ure2 PrD with its K. lactis homolog and the Saccharomycodes ludwigii Sup35 PrD to that of Pichia methanolica (Figure 6 )]. Thus, these regions have acquired many changes in sequence, yet they retain both the unusual amino acid composition characteristic of the S. cerevisiae PrDs and the capacity to form prions. We suggest that these observations support the hypothesis that the capacity of these domains to function as prions is evolutionarily conserved. Moreover, this capacity is derived from their unusual amino acid composition, not from their absolute sequences.
The potential evolutionary significance of [URE3] is not obvious. However, some ure2, and presumably [URE3] strains, grow better than wild-type strains in the presence of high concentrations of Na + , Li + , and Mn 2+ (181) , and reach a higher biomass than wild-type strains when grown in the presence of grape juices (130) . Natural populations may also benefit from being able to constitutively use a wide array of good and poor nitrogen sources, as is the case in ure2 and [URE3] strains.
One interesting hypothesis for an adaptive value for [PSI + ] was that the translational read through it causes would produce a constitutive heat shock response and make cells constitutively thermotolerant (55). Although this was true in some strains, it was not true in most strains tested [(55, 163) ] strains are usually indistinguishable. However, differences in growth or survival often occur when such sets are grown under other conditions, including a variety of carbon and nitrogen sources, and in the presence of potentially toxic salts, metals, and inhibitors of diverse cellular processes including DNA replication, signal transduction, protein glycosylation, and microtubule dynamics (163) . In an extensive study using more than 150 If prions are beneficial, how may novel prions be created under natural circumstances? One explanation is that prion domains are modular and transferable. Sup35NM can be transferred to an unrelated transcriptional activator to create a novel prion that regulates transcriptional initiation rather than translational termination (99) . This chimeric prion protein can exist in two stable, but interchangeable, functional states, which are independent of the prion conformation of Sup35. Thus, new prions may arise stochastically through recombination that appends sequences encoding PrDs to other genes in the genome.
HOW WIDESPREAD ARE PRIONS?
How many other prion proteins are there? To address this fascinating question, an algorithm was used to search the proteomes of 31 organisms for proteins containing at least 30 Gln or Asn residues within an 80-amino-acid region (113) . Proteins fitting this criterion were nearly absent from the 28 archeal, thermophilic, and mesophilic bacterial proteomes examined. In contrast, they constituted a surprisingly large fraction of eukaryotic proteins, as much as several percent of the total. S. cerevisiae had 107 candidates, or about 1.69% of the total proteins. This estimate is consistent with another, independently obtained with a more stringent algorithm (>50 consecutive residues containing at least 45% Q/N and 60% polar residues) (L. Li ] were found using similar database searches (133, 146) . Notably, some prions that are not rich in Asn and Gln, such as HET-s and PrP, are missed by such searches, suggesting that these searches are still underestimating the number of possible prion proteins.
The results of directed searches and the mere fact that prions occur in yeast, filamentous fungi, and mammals strongly suggest that prions are widely dispersed throughout the living world and underlie a wide variety of biological processes. Prions may epigenetically modulate chromatin structure and function (101), mediate homologous chromosome pairing (153) , comprise developmental switches (101) , and participate in organelle inheritance.
Although the self-perpetuating mechanism of the fungal prions is closely related to amyloid formation, some as yet unrecognized prions might be propagated through entirely different mechanisms. Indeed, there are other novel selfassembling protein structures that are unrelated to amyloids (32, 77, 79) . Similarly, there may be mechanisms to partition prions faithfully other than stochastic division of cytoplasmic content. Associations with cellular structures, such as organelles or outer membranes, can mediate inheritance of proteins. Indeed, one example of multigenerational cortical inheritance is the protein Rax2, which orients bud polarity in yeast (21) . Another is cortical inheritance of the pattern of cilia on the surface of Paramecium (7, 179) .
Finally, more than one prion can exist in a cell, and the presence of a prion can increase the likelihood that another will appear (45, 118). Thus, different combinations of prions within a cell might produce a wide variety of heritable phenotypes, all without necessitating any underlying changes in the genome. Clearly, identifying prions and ascertaining their roles in biology will occupy scientists for years to come.
